Hideaki Fujii

This inventor holds 17 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Nippon Chemiphar Co., Ltd., Dai Nippon Insatsu Kabushiki Kaisha, Hitachi, Ltd.. Active years: 1992-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hideaki Fujii. Retrieved from https://idiyas.com/inventor/hideaki-fujii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 4)

% Patents Active = 94.1

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 4.2

ph-index = 6

Forward Citations = 128(Granted Patents)

Location History:

Kanagawa, JP (2015 - 2017)
Tokyo, JP (1992 - 2023)

Company Filing History:

6 out of 132

Nippon Chemiphar Co., Ltd.

patents

5 out of 412

Dai Nippon Insatsu Kabushiki Kaisha

Dai Nippon Printing Co., Ltd.

patents

5. 2 out of 102

The Kitasato Institute

patents

6. 1 out of 59

Asahi Kasei Fibers Corporation

patents

where one patent can have more than one assignee

Years Active: 1992-2024

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109209 - Use of morphinan derivatives for treatment of opioid delta receptor agonist-related disease (2024-10-08),

2. 11643411 - Morphinan derivative (2023-05-09),

3. 11633392 - Use of morphinan derivative for therapeutic treatment of opioid delta receptor agonist-related disease (2023-04-25),

4. 10442802 - Morphinan derivative (2019-10-15),

5. 10395396 - X-ray CT apparatus, reconfiguration arithmetic apparatus, and X-ray CT image generation method (2019-08-27),

6. 10342500 - X-ray CT apparatus, upsampling method of projection data, and image reconstruction method (2019-07-09),

7. 10207212 - Filter material (2019-02-19),

8. 9895124 - X-ray CT apparatus and image reconstruction method (2018-02-20),

9. 9624223 - Morphinan derivative (2017-04-18),

10. 8952030 - Morphinan derivative (2015-02-10),

11. 6113836 - Method of forming thick film pattern and material for forming thick film (2000-09-05),

12. 5814267 - Method of forming thick film pattern and material for forming thick film (1998-09-29),

13. 5703433 - Plasma display panel and method for forming fluorescent screens of the (1997-12-30),

14. 5601468 - Plasma display panel and method for forming fluorescent screens of the (1997-02-11),

15. 5580511 - Method of forming thick film pattern and material for forming thick film (1996-12-03),

Title: Innovations of Hideaki Fujii in Pharmaceutical Development

Introduction

Hideaki Fujii is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the field of pharmaceuticals. With a total of 17 patents to his name, he has made remarkable strides in developing treatments for various medical conditions.

Latest Patents

Fujii's latest patents include a groundbreaking method for the therapeutic treatment of pain-associated anxiety or depression in mammals. This method involves administering an effective amount of a pharmaceutical composition containing a morphinan derivative that exhibits opioid δ receptor agonist activity. The morphinan derivative is represented by a specific general formula, where various substituents and configurations are defined to enhance its therapeutic efficacy. This innovative approach aims to provide relief for patients suffering from opioid delta receptor agonist-related diseases.

Career Highlights

Throughout his career, Hideaki Fujii has worked with notable companies such as Nippon Chemiphar Co., Ltd. and Dai Nippon Insatsu Kabushiki Kaisha. His work in these organizations has allowed him to develop and refine his inventions, contributing to advancements in pharmaceutical science.

Collaborations

Fujii has collaborated with esteemed colleagues, including Hiroshi Nagase and Eriko Nakata. These partnerships have fostered a collaborative environment that has led to innovative solutions in the pharmaceutical industry.

Conclusion

Hideaki Fujii's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific advancements. His work continues to impact the field positively, paving the way for future developments in medical treatments.

Profile summary based on public USPTO records.